Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach.

Brain Commun · 2021 · PMC8568847 · PMID 34755110

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

ANOVA of these metabolites revealed significant differences across the four patient groups, with a clear trend with time since relapse onset.

also in 19,460 other papers

a decreasing trendno p-value reported

Both lysine and asparagine were higher in R compared to LR ≥ 24 M patients, and showed a decreasing trend with time away from relapse ( Fig. 4A and B ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.